Editorial: New marketable discoveries in nanobiotechnology

Ronnie G Willaert; Sandor Kasas

doi:10.3389/fbioe.2024.1412587

Editorial: New marketable discoveries in nanobiotechnology

Front Bioeng Biotechnol. 2024 Apr 19:12:1412587. doi: 10.3389/fbioe.2024.1412587. eCollection 2024.

Authors

Ronnie G Willaert^{1

2}, Sandor Kasas^{2

3

4}

Affiliations

¹ Research Group Structural Biology Brussels, Alliance Research Group VUB-UGhent NanoMicrobiology (NAMI), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
² International Joint Research Group VUB-EPFL BioNanotechnology & NanoMedicine (NANO), Brussels, Switzerland.
³ Laboratory of Biological Electron Microscopy, Ecole Polytechnique Fédérale de Lausanne (EPFL) and University of Lausanne, Lausanne, Switzerland.
⁴ Centre Universitaire Romand de Médecine Légale, UFAM, Université de Lausanne, Lausanne, Switzerland.

No abstract available

Keywords: 3D printing; cardiac tissue contractile force; fomatidine nanoparticles; machine-learning (ML); nanochitosan encapsulation; nanomotion detection; orthopedic surgery; thryroid-stimulating hormone assay.

Publication types

Editorial

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by the Belgian Federal Science Policy Office (Belspo) and the European Space Agency (ESA), grant number PRODEX Flumias Nanomotion; FWO, grant number I002620; FWO-SNSF, grant number 310030L_197946; SK is supported by SNSF grants CRSII5_173863.